{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:22:59Z","timestamp":1782285779263,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T00:00:00Z","timestamp":1703203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00198-023-06972-8","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T03:27:45Z","timestamp":1703215665000},"page":"653-658","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenopausal osteoporosis at the bone tissue level"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5128-7361","authenticated-orcid":false,"given":"P.","family":"Chavassieux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Chapurlat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,22]]},"reference":[{"key":"6972_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/BF01880415","volume":"1","author":"MA Arlot","year":"1990","unstructured":"Arlot MA, Delmas PD, Chappard D, Meunier PJ (1990) Trabecular and endocortical bone remodeling in postmenopausal osteoporosis: comparison with normal postmenopausal women. Osteoporos Int 1:41\u201349. https:\/\/doi.org\/10.1007\/BF01880415","journal-title":"Osteoporos Int"},{"key":"6972_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s002239900135","volume":"59","author":"R Dresner-Pollak","year":"1996","unstructured":"Dresner-Pollak R, Parker RA, Poku M, Thompson J, Seibel MJ, Greenspan SL (1996) Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcif Tissue Int 59:328\u2013333. https:\/\/doi.org\/10.1007\/s002239900135","journal-title":"Calcif Tissue Int"},{"key":"6972_CR3","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1359\/jbmr.1999.14.8.1404","volume":"14","author":"DC Bauer","year":"1999","unstructured":"Bauer DC, Sklarin PM, Stone KL, Black DM, Nevitt MC, Ensrud KE, Arnaud CD, Genant HK, Garnero P, Delmas PD, Lawaetz H, Cummings SR, For The Study Of Osteoporotic Fractures Research Group (1999) Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures. J Bone Miner Res 14:1404\u20131410. https:\/\/doi.org\/10.1359\/jbmr.1999.14.8.1404","journal-title":"J Bone Miner Res"},{"key":"6972_CR4","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","volume":"11","author":"P Garnero","year":"1996","unstructured":"Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Breart G, Meunier PJ, Delmas PD (1996) Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 11:1531\u20131538. https:\/\/doi.org\/10.1002\/jbmr.5650111021","journal-title":"J Bone Miner Res"},{"key":"6972_CR5","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1359\/jbmr.1998.13.9.1431","volume":"13","author":"SL Greenspan","year":"1998","unstructured":"Greenspan SL, Parker RA, Fergusson L, Rosen HN, Maitland-Ramsey L, Karpf DB (1998) Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial. J Bone Miner Res 13:1431\u20131438. https:\/\/doi.org\/10.1359\/jbmr.1998.13.9.1431","journal-title":"J Bone Miner Res"},{"key":"6972_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/s8756-3282(98)00044-1","volume":"22","author":"P Ravn","year":"1998","unstructured":"Ravn P, Christensen JO, Baumann M, Clemmesen B (1998) Changes in biochemical markers and bone mass after withdrawal of ibandronate treatment: prediction of bone mass changes during treatment. Bone 22:559\u2013564. https:\/\/doi.org\/10.1016\/s8756-3282(98)00044-1","journal-title":"Bone"},{"key":"6972_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/s8756-3282(98)00183-5","volume":"24","author":"P Ravn","year":"1999","unstructured":"Ravn P, Clemmesen B, Christiansen C, for the Alendronate Osteoporosis Prevention Study Group (1999) Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Bone 24:237\u2013244. https:\/\/doi.org\/10.1016\/s8756-3282(98)00183-5","journal-title":"Bone"},{"key":"6972_CR8","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1210\/jcem.79.6.7989477","volume":"79","author":"P Garnero","year":"1994","unstructured":"Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD (1994) Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 79:1693\u20131700. https:\/\/doi.org\/10.1210\/jcem.79.6.7989477","journal-title":"J Clin Endocrinol Metab"},{"key":"6972_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s001980070088","volume":"11","author":"AC Looker","year":"2000","unstructured":"Looker AC, Bauer DC, Chesnut CH III, Gundberg CM, Hochberg MC, Klee G, Kleerekoper M, Watts NB, Bell NH (2000) Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporos Int 11:467\u2013480. https:\/\/doi.org\/10.1007\/s001980070088","journal-title":"Osteoporos Int"},{"key":"6972_CR10","doi-asserted-by":"publisher","first-page":"4662","DOI":"10.1210\/jc.2015-2957","volume":"100","author":"P Chavassieux","year":"2015","unstructured":"Chavassieux P, Portero-Muzy N, Roux JP, Garnero P, Chapurlat R (2015) Are biochemical markers of bone turnover representative of bone histomorphometry in 370 postmenopausal women? J Clin Endocrinol Metab 100:4662\u20134668. https:\/\/doi.org\/10.1210\/jc.2015-2957","journal-title":"J Clin Endocrinol Metab"},{"key":"6972_CR11","doi-asserted-by":"publisher","unstructured":"Schini M, Vilaca T, Gossiel F, Salam S, Eastell R (2022) Bone turnover markers: basic biology to clinical applications. Endocr Rev:bnac031. https:\/\/doi.org\/10.1210\/endrev\/bnac031","DOI":"10.1210\/endrev\/bnac031"},{"key":"6972_CR12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bone.2007.06.010","volume":"41","author":"E Seeman","year":"2007","unstructured":"Seeman E (2007) Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy? Bone 41:308\u2013317. https:\/\/doi.org\/10.1016\/j.bone.2007.06.010","journal-title":"Bone"},{"key":"6972_CR13","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s00198-022-06457-0","volume":"33","author":"SE B\u00f8nl\u00f8kke","year":"2022","unstructured":"B\u00f8nl\u00f8kke SE, Rand MS, Haddock B, Arup S, Smith CD, Jensen JEB, Schwarz P, Hovind P, Oturai PS, Jensen LT, M\u00f8ller S, Eiken P, Rubin KH, Hitz MF, Abrahamsen B, J\u00f8rgensen NR (2022) Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover study. Osteoporos Int 33:2155\u20132164. https:\/\/doi.org\/10.1007\/s00198-022-06457-0","journal-title":"Osteoporos Int"},{"key":"6972_CR14","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1359\/JBMR.051018","volume":"21","author":"DC Bauer","year":"2006","unstructured":"Bauer DC, Garnero P, Hochberg MC, Santora A, Delmas P, Ewing SK, Black DM, for the Fracture Intervention Research Group (2006) Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial. J Bone Miner Res 21:292\u2013299. https:\/\/doi.org\/10.1359\/JBMR.051018","journal-title":"J Bone Miner Res"},{"key":"6972_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1359\/JBMR.0301231","volume":"19","author":"MJ Seibel","year":"2004","unstructured":"Seibel MJ, Naganathan V, Barton I, Grauer A (2004) Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate. J Bone Miner Res 19:323\u2013329. https:\/\/doi.org\/10.1359\/JBMR.0301231","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"6972_CR16","first-page":"S350","volume":"10","author":"L Hirsch","year":"1995","unstructured":"Hirsch L, Watts N, Mellwrain H, Rodriguez J, Romangwicz A, Daifotis A, Kher U, Santora A (1995) Efficacy of alendronate to increase BMD is similar irrespective of baseline bone turnover, BMD and age. J Bone Miner Res 10(Suppl 1):S350","journal-title":"J Bone Miner Res"},{"key":"6972_CR17","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/s0002-9343(96)00282-3","volume":"101","author":"JR Tucci","year":"1996","unstructured":"Tucci JR, Tonino RP, Emkey RD, Peverly CA, Kher U, Santora AC, for the US Alendronate Phase III Osteoporosis Treatment Study Group (1996) Effects of three years of oral alendronate treatment in postmenopausal women with osteoporosis. Am J Med 101:488\u2013501. https:\/\/doi.org\/10.1016\/s0002-9343(96)00282-3","journal-title":"Am J Med"},{"issue":"7","key":"6972_CR18","doi-asserted-by":"publisher","first-page":"e0271555","DOI":"10.1371\/journal.pone.0271555","volume":"17","author":"HH Malluche","year":"2022","unstructured":"Malluche HH, Davenport DL, Lima F, Monier-Faugere MC (2022) Prevalence of low bone formation in untreated patients with osteoporosis. PLoS One 17(7):e0271555. https:\/\/doi.org\/10.1371\/journal.pone.0271555","journal-title":"PLoS One"},{"key":"6972_CR19","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1080\/03008200290000934","volume":"43","author":"G Boivin","year":"2002","unstructured":"Boivin G, Meunier PJ (2002) Changes in bone remodeling rate influence the degree of mineralization of bone. Connect Tissue Res 43:535\u2013537. https:\/\/doi.org\/10.1080\/03008200290000934","journal-title":"Connect Tissue Res"},{"key":"6972_CR20","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/jbmr.2074","volume":"29","author":"P Chavassieux","year":"2014","unstructured":"Chavassieux P, Meunier PJ, Roux JP, Portero-Muzy N, Pierre M, Chapurlat R (2014) Bone histomorphometry of transiliac paired bone biopsies after 6 or 12 months of treatment with oral strontium ranelate in 387 osteoporotic women. Randomized comparison to alendronate. J Bone Miner Res 29:618\u2013628. https:\/\/doi.org\/10.1002\/jbmr.2074","journal-title":"J Bone Miner Res"},{"key":"6972_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster DW, Compston JE, Drezner MK, Glorieux F, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (2013) Standardized nomenclature, symbols and units for bone histomorphometry. A 2012 update of the report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res 28:2\u201317. https:\/\/doi.org\/10.1002\/jbmr.1805","journal-title":"J Bone Miner Res"},{"key":"6972_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/B978-0-12-384864-2.00011-1","volume-title":"Statistics in medicine","author":"RH Riffenburgh","year":"2012","unstructured":"Riffenburgh RH (2012) Test on ranked data. In: Statistics in medicine, 3rd edn. Academic Press, San Diego, pp 221\u2013248","edition":"3"},{"key":"6972_CR23","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1359\/jbmr.1997.12.4.624","volume":"12","author":"S Gonnelli","year":"1997","unstructured":"Gonnelli S, Cepollaro C, Pondrelli C, Martini S, Monaco R, Gennari C (1997) The usefulness of bone turnover in predicting the response to transdermal estrogen therapy in postmenopausal osteoporosis. J Bone Miner Res 12:624\u2013631. https:\/\/doi.org\/10.1359\/jbmr.1997.12.4.624","journal-title":"J Bone Miner Res"},{"key":"6972_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s002239900713","volume":"65","author":"S Gonnelli","year":"1999","unstructured":"Gonnelli S, Cepollaro C, Pondrelli C, Martini S, Montagnani A, Monaco R, Gennari C (1999) Bone turnover and the response to alendronate treatment in postmenopausal osteoporosis. Calcif Tissue Int 65:359\u2013364. https:\/\/doi.org\/10.1007\/s002239900713","journal-title":"Calcif Tissue Int"},{"key":"6972_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.bone.2013.09.010","volume":"57","author":"J Michelsen","year":"2013","unstructured":"Michelsen J, Wallaschofski H, Friedrich N, Spielhagen C, Rettig R, Ittermann T, Nauck M, Hannemann A (2013) Reference intervals for serum concentrations of three bone turnover markers for men and women. Bone 57:399\u2013404. https:\/\/doi.org\/10.1016\/j.bone.2013.09.010","journal-title":"Bone"},{"key":"6972_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.kint.2022.04.030","volume":"102","author":"HS J\u00f8rgensen","year":"2022","unstructured":"J\u00f8rgensen HS, Ferreira AC, D\u2019Haese P, Haarhaus M, Vervloet M, Lafage-Proust MH, Ferreira A, Evenepoel P, and the European Renal Osteodystrophy (EUROD) workgroup, on behalf of Chronic Kidney Disease-Mineral and Bone Disorder Working Group (CKD-MBD WG) (2022) Bone histomorphometry for the diagnosis of renal osteodystrophy: a call for harmonization of reference ranges. Kidney Int 102:431\u2013434. https:\/\/doi.org\/10.1016\/j.kint.2022.04.030","journal-title":"Kidney Int"},{"key":"6972_CR27","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00198-008-0717-9","volume":"20","author":"T Diab","year":"2009","unstructured":"Diab T, Allen MR, Burr DB (2009) Alendronate treatment results in similar level of trabecular bone remodeling in the femoral neck and vertebra. Osteoporos Int 20:647\u2013652. https:\/\/doi.org\/10.1007\/s00198-008-0717-9","journal-title":"Osteoporos Int"},{"key":"6972_CR28","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","volume":"333","author":"UA Liberman","year":"1995","unstructured":"Liberman UA, Weiss SR, Br\u00f6ll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW, Dequeker J, Favus M, Seeman E, Recker RR, Capizzi T, Santora AC, Lombardi A, Shah RV, Hirsch LJ, Karpf DB, For The Alendronate Phase III Osteoporosis Treatment Study Group (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437\u20131443. https:\/\/doi.org\/10.1056\/NEJM199511303332201","journal-title":"N Engl J Med"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06972-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-023-06972-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06972-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T10:11:41Z","timestamp":1711015901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-023-06972-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,22]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["6972"],"URL":"https:\/\/doi.org\/10.1007\/s00198-023-06972-8","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,22]]},"assertion":[{"value":"27 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}